UA27043C2 - Мікросферичhі частиhки для пареhтеральhої іh'єкції фармацевтичhо активhої речовиhи при її коhтрольоваhому виділеhhі в оргаhізмі після іh'єкції, спосіб їх одержаhhя та суспеhзія hа осhові даhих мікросфер - Google Patents

Мікросферичhі частиhки для пареhтеральhої іh'єкції фармацевтичhо активhої речовиhи при її коhтрольоваhому виділеhhі в оргаhізмі після іh'єкції, спосіб їх одержаhhя та суспеhзія hа осhові даhих мікросфер

Info

Publication number
UA27043C2
UA27043C2 UA93004686A UA93004686A UA27043C2 UA 27043 C2 UA27043 C2 UA 27043C2 UA 93004686 A UA93004686 A UA 93004686A UA 93004686 A UA93004686 A UA 93004686A UA 27043 C2 UA27043 C2 UA 27043C2
Authority
UA
Ukraine
Prior art keywords
injection
pharmaceutically active
microspheres
organism
producing
Prior art date
Application number
UA93004686A
Other languages
English (en)
Russian (ru)
Inventor
Флорес Жозе Гарца
Сото Лаура П. Лаісека
Сото Лаура П. Лаисека
Пісардо Жозе Гіллен
Писардо Жозе Гиллен
Урібе Хуан Ангелес
Урибе Хуан Ангелес
Original Assignee
Аплікасьонес Фармацеутікас С.А. Де С.В.
Апликасёнес Фармацеутикас С.А. Де С.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Аплікасьонес Фармацеутікас С.А. Де С.В., Апликасёнес Фармацеутикас С.А. Де С.В. filed Critical Аплікасьонес Фармацеутікас С.А. Де С.В.
Publication of UA27043C2 publication Critical patent/UA27043C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Винахід надає спосіб поліпшення контролю за фармакокінетичними і фармакологічними властивостями фармацевтично активних речовин. Він стосується також частинок активних речовин і їх застосування в рецептурах для ін'єкцій з пролонгованим виділенням. Мікросферичні частинки для парентеральної ін'єкції фармацевтично активної речовини є твердими непористими мікросферами, що мають діаметр 1 – 300 мкм, і виконані з однієї або декількох фармацевтично активних речовин.
UA93004686A 1990-06-14 1991-06-12 Мікросферичhі частиhки для пареhтеральhої іh'єкції фармацевтичhо активhої речовиhи при її коhтрольоваhому виділеhhі в оргаhізмі після іh'єкції, спосіб їх одержаhhя та суспеhзія hа осhові даhих мікросфер UA27043C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9007416A FR2663223B1 (fr) 1990-06-14 1990-06-14 Forme galenique parenterale.
PCT/EP1991/001096 WO1991019484A1 (fr) 1990-06-14 1991-06-12 Composition pharmaceutique injectable

Publications (1)

Publication Number Publication Date
UA27043C2 true UA27043C2 (uk) 2000-02-28

Family

ID=9397598

Family Applications (1)

Application Number Title Priority Date Filing Date
UA93004686A UA27043C2 (uk) 1990-06-14 1991-06-12 Мікросферичhі частиhки для пареhтеральhої іh'єкції фармацевтичhо активhої речовиhи при її коhтрольоваhому виділеhhі в оргаhізмі після іh'єкції, спосіб їх одержаhhя та суспеhзія hа осhові даhих мікросфер

Country Status (30)

Country Link
US (3) US5360616A (uk)
EP (1) EP0533739B1 (uk)
JP (1) JP2675675B2 (uk)
KR (1) KR0157439B1 (uk)
CN (1) CN1057442C (uk)
AT (1) ATE109658T1 (uk)
AU (1) AU661275B2 (uk)
BG (1) BG61179B1 (uk)
BR (1) BR9106545A (uk)
CA (1) CA2085344C (uk)
CZ (1) CZ286793B6 (uk)
DE (1) DE69103419T2 (uk)
DK (1) DK0533739T3 (uk)
ES (1) ES2059142T3 (uk)
FI (1) FI107698B (uk)
FR (1) FR2663223B1 (uk)
HU (1) HUT68709A (uk)
IE (1) IE62679B1 (uk)
IL (1) IL98459A (uk)
NO (1) NO302998B1 (uk)
NZ (1) NZ238542A (uk)
PL (1) PL167234B1 (uk)
PT (1) PT97975B (uk)
RU (1) RU2104692C1 (uk)
SK (1) SK280564B6 (uk)
TN (1) TNSN91048A1 (uk)
UA (1) UA27043C2 (uk)
UY (1) UY23240A1 (uk)
WO (1) WO1991019484A1 (uk)
ZA (1) ZA914550B (uk)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663224B1 (fr) * 1990-06-14 1995-01-20 Applicationes Farmaceuticas Sa Forme galenique parenterale.
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
GB9313642D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
FR2732621B1 (fr) * 1995-04-10 1997-06-06 Rhone Poulenc Chimie Perles d'un produit presentant le phenomene de surfusion et leur procede d'obtention
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
US6028057A (en) * 1998-02-19 2000-02-22 Thorn Bioscience, Llc Regulation of estrus and ovulation in gilts
AU753278B2 (en) * 1998-02-25 2002-10-10 Abbott Laboratories Butorphanol sustained release formulations
US6287693B1 (en) * 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
WO2001013885A1 (en) * 1999-08-20 2001-03-01 Norton Healthcare Ltd. Method to produce powders for pulmonary or nasal administration
US20030055075A1 (en) * 2001-07-13 2003-03-20 Rubsamen Reid M. Programmable controlled release injectable opioid formulation
US20070254008A1 (en) * 2001-07-13 2007-11-01 Flow Focusing, Inc. Antibiotic formulation and method of treatment
US20070254009A1 (en) * 2001-07-13 2007-11-01 Flow Focusing, Inc. Antibiotic/bone morphogenic protein formulation and method of treatment
GB0117696D0 (en) * 2001-07-20 2001-09-12 Bradford Particle Design Plc Particle information
ES2340422T3 (es) * 2003-06-13 2010-06-02 Skendi Finance, Ltd. Microparticulas constituidas por estradiol y colesterol.
US20050032811A1 (en) 2003-08-06 2005-02-10 Josiah Brown Methods for administering aripiprazole
US9532995B2 (en) 2003-09-03 2017-01-03 Miscon Trading S.A. Methods for the treatment of endometriosis
EP3025722B1 (en) 2003-10-03 2020-05-27 Thorn BioScience, LLC Process for the synchronization of ovulation for timed breeding without heat detection
BRPI0415531B8 (pt) * 2003-10-23 2021-05-25 Otsuka Pharma Co Ltd formulação de aripiprazol injetável estéril de liberação controlada e método para a sua preparação
US7413690B1 (en) 2003-10-29 2008-08-19 The University Of Mississippi Process and apparatus for producing spherical pellets using molten solid matrices
US7491263B2 (en) 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
US7392635B2 (en) * 2005-06-09 2008-07-01 Tipper Tie, Inc. Breech loader packaging systems and associated breech loading chutes and methods
US20070197435A1 (en) * 2006-02-17 2007-08-23 Webel Stephen K Process for the synchronization of ovulation for timed breeding without heat detection
CA2667890C (en) 2006-10-31 2015-01-27 Surmodics Pharmaceuticals, Inc. Spheronized polymer particles
JP4879349B2 (ja) 2007-07-31 2012-02-22 大塚製薬株式会社 アリピプラゾール懸濁液及び凍結乾燥製剤の製造方法
JP2011516606A (ja) * 2008-04-14 2011-05-26 ポジ ビジョナリー ソリューションズ エルエルピー 様々な治療指標に必要な血漿プロゲステロン濃度を得るための方法および医薬組成物
BR122013009981B1 (pt) 2009-04-23 2020-02-11 United-Ah Ii, Llc Composição para sincronizar o tempo de inseminação
UY33103A (es) 2009-12-15 2011-07-29 Techsphere S A De C V Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico
CN113398243A (zh) 2012-11-28 2021-09-17 联合动物健康第二有限责任公司 用于同步小母猪的授精时间的方法
WO2017105512A1 (en) 2015-12-18 2017-06-22 Proinvet Innovations S.A. Formulations and methods for controlling the reproductive cycle and ovulation
US12290523B2 (en) 2016-02-24 2025-05-06 Eastern Virginia Medical School Formulation of long-acting levonorgestrel butanoate injectable depot suspension
CN106063783B (zh) * 2016-06-16 2019-03-12 浙江爱生药业有限公司 一种黄体酮缓释微囊制剂及其制备方法
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
CN115212170B (zh) * 2021-04-19 2024-01-26 中国人民解放军军事科学院军事医学研究院 一种致密圆整的药物球形微晶及其制备方法和其应用
CN116036022A (zh) * 2021-12-24 2023-05-02 中国人民解放军军事科学院军事医学研究院 一种新型的含载体材料的药物微球制备及应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE670438A (uk) * 1964-10-06 1966-01-31
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3928566A (en) * 1970-08-14 1975-12-23 Du Pont Lyophilized biological products
JPS5017525A (uk) * 1973-06-14 1975-02-24
CA1077842A (en) * 1975-10-09 1980-05-20 Minnesota Mining And Manufacturing Company Albumin medicament carrier system
US4244949A (en) * 1978-04-06 1981-01-13 The Population Council, Inc. Manufacture of long term contraceptive implant
US4349580A (en) * 1978-08-18 1982-09-14 Queen's University At Kingston Process and solution for preserving green plant tissues
US4384975A (en) * 1980-06-13 1983-05-24 Sandoz, Inc. Process for preparation of microspheres
US4349530A (en) * 1980-12-11 1982-09-14 The Ohio State University Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
IL79407A (en) * 1985-08-01 1991-03-10 Theragenics Corp System and method for delivering insoluble material into a living body
ES2039219T3 (es) * 1986-08-11 1993-09-16 American Cyanamid Company Composiciones para administracion parenteral y su uso.
US4837381A (en) * 1986-08-11 1989-06-06 American Cyanamid Company Compositions for parenteral administration and their use
US4892734A (en) * 1987-04-06 1990-01-09 Endocon, Inc. Dispensing paste for forming medicinal pellets
US4748024A (en) * 1987-04-06 1988-05-31 Endocon, Inc. Flash flow fused medicinal implants
EP0357644B1 (en) * 1987-04-06 1994-08-17 Aberlyn Capital Management Limited Partnership Flash flow fused medicinal implants
DK0432232T3 (da) * 1989-05-01 1994-01-31 Alkermes Inc Fremgangsmåde til fremstilling af små partikler af biologisk aktive molekyler
US5019400A (en) * 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres

Also Published As

Publication number Publication date
EP0533739A1 (fr) 1993-03-31
DE69103419D1 (de) 1994-09-15
SK280564B6 (sk) 2000-03-13
AU8084791A (en) 1992-01-07
BG61179B1 (bg) 1997-02-28
FI107698B (fi) 2001-09-28
HUT68709A (en) 1995-07-28
WO1991019484A1 (fr) 1991-12-26
PT97975B (pt) 1998-11-30
AU661275B2 (en) 1995-07-20
FR2663223B1 (fr) 1994-12-02
ATE109658T1 (de) 1994-08-15
ES2059142T3 (es) 1994-11-01
CN1057442C (zh) 2000-10-18
UY23240A1 (es) 1991-07-12
IE62679B1 (en) 1995-02-22
CS181691A3 (en) 1992-06-17
NO924792D0 (no) 1992-12-11
US5633014A (en) 1997-05-27
FI925661A0 (fi) 1992-12-11
IE912017A1 (en) 1991-12-18
CN1057961A (zh) 1992-01-22
PL290677A1 (en) 1992-11-30
KR0157439B1 (ko) 1998-11-16
NZ238542A (en) 1993-09-27
FI925661L (fi) 1992-12-11
BG97166A (bg) 1993-12-24
CA2085344C (en) 1998-06-30
IL98459A (en) 1996-09-12
NO924792L (no) 1993-02-03
CZ286793B6 (cs) 2000-07-12
ZA914550B (en) 1992-03-25
TNSN91048A1 (fr) 1992-10-25
NO302998B1 (no) 1998-05-18
DE69103419T2 (de) 1995-03-30
PL167234B1 (pl) 1995-08-31
US5360616A (en) 1994-11-01
US5512303A (en) 1996-04-30
FR2663223A1 (fr) 1991-12-20
EP0533739B1 (fr) 1994-08-10
HU9203958D0 (en) 1993-03-29
RU2104692C1 (ru) 1998-02-20
PT97975A (pt) 1992-04-30
DK0533739T3 (da) 1995-01-09
IL98459A0 (en) 1992-07-15
BR9106545A (pt) 1993-06-01
CA2085344A1 (en) 1991-12-15
JP2675675B2 (ja) 1997-11-12
JPH05507694A (ja) 1993-11-04

Similar Documents

Publication Publication Date Title
BRENTARI Theoretical foundations of American sign language phonology
RU92016471A (ru) Твердая непористая микросфера, способ ее получения и применение в фармакологическом препарате
BG97166A (bg) Лекарствена парентерална форма с депо действие
SE8705043D0 (sv) Hydrosols of pharmacologically active agents and their pharmaceutical compositions comprising them
EP1770163A3 (en) Antagonists of interleukin-15
IT1247472B (it) Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
CA2046830A1 (en) Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
ATE281886T1 (de) Yttria partikelförmiges gut
IE46009L (en) Superficially porous macroparticles
NO307091B1 (no) Nye pyrido[3,2-e]pyrazinoner, legemiddel inneholdende samme, samt anvendelse av samme for fremstilling av legemiddel
ES2094781T3 (es) Composicion farmaceutica de microparticulas con liberacion controlada y su proceso de preparacion.
MY111172A (en) Perfume particles.
EP1027038A4 (en) PHARMACEUTICAL PREPARATIONS WITH TASTE MASK
CA2064861A1 (fr) Galenique injectable a effet retarde
DE69302634D1 (de) Pfropfcopolymer, Verfahren zur Herstellung davon und dieses Copolymer als aktive Komponente enthaltende Weichmacher
SE8704158L (sv) Mikrosfaerer, foerfarande foer framstaellning daerav och anvaendning daerav
YU48420B (sh) Postupak za dobijanje biološki razgradljivih mikročestica sa dugotrajnim delovanjem
KR920011478A (ko) 안과용 미소구
NO911200L (no) Fremgangsmaate for fremstilling av selektive adenosin-receptor midler.
MY105555A (en) Heterocyclicguanidines as 5ht 3 antagonists.
IT1293088B1 (it) Microparticelle per il rilascio controllato di molecole biologicamente attive e loro uso in terapia, profilassi e diagnostica in vitro e in
NO922282D0 (no) Formulering for vedvarende frigivelse av acetazolamid, samt fremgangsmaate for fremstilling av formuleringen
IT8919524A0 (it) Derivati dal 1 arilsolfonil 2 piperidone, loro procedimento di preparazione e loro impiego come farmaci.
ATE87200T1 (de) Polymer-teilchen.
GR3018795T3 (en) Emulsion-free emulsion polymers in sustained-release pharmaceutical compositions and their production